Literature DB >> 9351567

Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases.

O Lin1, G Frizzera.   

Abstract

Castleman's disease of hyaline-vascular type (HV CD) may rarely be associated with a confusing variety of stromal cell overgrowths and neoplasms. We report here on the pathologic and clinical findings of 10 such cases. In addition to the usual complex histoimmunophenotype of the stroma of HV CD and some unusual features that mimicked neoplasms, we observed focal proliferations of angiomyoid (five cases) and follicular dendritic cell type (five cases). The former were nonneoplastic growths featuring compact tangles of spindle cells, exhibiting immunoreactivity for smooth muscle actin and interpreted as vessel-related pericytes and myoid cells. The latter were neoplastic growths of oval to spindle cells intermixed with lymphocytes; the tumor cells grew in long, intersecting bundles, featured various degree of atypia, and expressed the markers of follicular dendritic cells (CD21, CD35, KiM4p). The two types were clinically distinct. Four of five patients with angiomyoid proliferations were young women, who presented with an abdominal mass and were cured by surgery; that is, they had a clinical profile similar to that of patients with the stroma-rich variant of HV CD. The follicular dendritic cell proliferations were in older patients of either gender presenting with masses at various sites, recapitulating the profile of follicular dendritic cell tumors arising independently from HV CD; in three patients with long-term follow-up, recurrences or metastases developed at various intervals from the initial diagnosis (1 1/6, 3 1/2, and 11 years), and one patient died as a result. This study confirms the potential for, and the variety of, stromal cell proliferations in HV CD. Because their biologic behavior differs, correct identification of these various proliferative lesions is clinically important.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351567     DOI: 10.1097/00000478-199711000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

1.  Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma.

Authors:  Lan Li; Yong-Hong Shi; Zhi-Juan Guo; Tian Qiu; Lei Guo; Hong-Ying Yang; Xun Zhang; Xin-Ming Zhao; Qin Su
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

2.  Follicular dendritic cell tumor of the mediastinum: expression of fractalkine and SDF-1alpha as mast cell chemoattractants.

Authors:  Catherine Guettier; Pierre Validire; Dominique Emilie; Viviane Tricottet; Mylène Sebagh; Aurora Anjo; Jean-Louis Misset; Michel Reynes
Journal:  Virchows Arch       Date:  2006-01-12       Impact factor: 4.064

3.  Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entity.

Authors:  Jinru Shia; Wen Chen; Laura H Tang; Diane L Carlson; Jin Qin; Jose G Guillem; Jennifer Nobrega; W Douglas Wong; David S Klimstra
Journal:  Virchows Arch       Date:  2006-06-07       Impact factor: 4.064

4.  A rare stroma-rich variant of hyaline-vascular Castleman's disease associated with calcifying fibrous pseudotumor.

Authors:  Haifen Ma; Maofen Jiang; Weihua Xiao
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 5.  Clinical features and outcome of patients with HIV-negative multicentric Castleman's disease treated with combination chemotherapy: a report on 10 patients.

Authors:  Shou-Hui Zhu; Yong-Hua Yu; Yong Zhang; Ju-Jie Sun; Da-Li Han; Jia Li
Journal:  Med Oncol       Date:  2013-02-12       Impact factor: 3.064

6.  Follicular dendritic cell sarcoma of the tonsil: case report and review of literature.

Authors:  Lei Bao; Ting Wang; Mengyao Liu; Fengjuan Xing
Journal:  Int J Clin Exp Pathol       Date:  2021-04-15

7.  Castleman's disease of the neck: report of 4 cases with unusual presentations.

Authors:  Lei Jiang; Liang Yu Zhao; Yuan Liu; Yun Fu Zhao
Journal:  J Oral Maxillofac Surg       Date:  2010-08-12       Impact factor: 1.895

8.  Development of a calcifying fibrous pseudotumour within a lesion of Castleman disease, hyaline-vascular subtype.

Authors:  J L Dargent; J Delplace; C Roufosse; J P Laget; L Lespagnard
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

9.  Transcriptome and unique cytokine microenvironment of Castleman disease.

Authors:  Anna Wing; Jason Xu; Wenzhao Meng; Aaron M Rosenfeld; Elizabeth Y Li; Gerald Wertheim; Michele Paessler; Adam Bagg; Dale Frank; Kai Tan; David T Teachey; Megan S Lim; Eline Luning Prak; David C Fajgenbaum; Vinodh Pillai
Journal:  Mod Pathol       Date:  2021-10-22       Impact factor: 8.209

10.  Completely resected follicular dendritic cell sarcoma of the posterior mediastinum: report of a case.

Authors:  Ryo Miyoshi; Makoto Sonobe; Ei Miyamoto; Hiroshi Date
Journal:  Surg Case Rep       Date:  2016-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.